Journal: Cells
Article Title: Sclerostin Alters Tumor Cell Characteristics of Oral Squamous Cell Carcinoma and May Be a Key Player in Local Bone Invasion
doi: 10.3390/cells13020137
Figure Lengend Snippet: Clinical patient characteristics and H-score values derived from semiquantitative immunohistochemical evaluation of sclerostin expression at the OSCC–jawbone interface. pT indicates the extent of primary OSCC (pT2: tumor extent ≤2 cm with depth of invasion >5 mm and ≤10 mm; or tumor extent >2 cm and ≤4 cm with depth of invasion ≤10 mm; pT3: tumor extent >2 cm and ≤4 cm with depth of invasion >10 mm; or tumor extension >4 cm with depth of invasion ≤10 mm; pT4a: tumor extension >4 cm with depth of invasion >10 mm; or tumor invades adjacent structures (e.g., through the cortical bone of the mandible or maxilla). pN indicates cervical lymph node metastasis (pN0: no lymph node metastasis; pN2b: metastasis in multiple ipsilateral nodes, none >6 cm in largest dimension, and no extranodal extension. pN2c: metastasis in bilateral or contralateral lymph nodes, none >6 cm in largest dimension, and no extranodal extension; pN3b: metastasis in one or more nodes and clinically evident extranodal extension). pM indicates distant metastases (pM0: no distant metastases). H-score values range from 0 to 300, with 0 indicating that no cells are positive and 300 indicating that all cells are strongly positive.
Article Snippet: The assay was performed according to the manufacturer’s instructions and the luciferase reaction was measured every 24 h. To analyze the influence of recombinant human (rh)-sclerostin (100-49, Peprotech, Hamburg, Germany) on cell proliferation, 1500 cells were seeded per well of a 96-well plate and four different concentrations of sclerostin (0; 1; 5; 10 ng/mL) were tested.
Techniques: Derivative Assay, Immunohistochemistry, Expressing